A genetically encoded BRET-based SARS-CoV-2 Mpro protease activity sensor

<p dir="ltr">The main protease, M<sup>pro</sup>, is critical for SARS-CoV-2 replication and an appealing target for designing anti-SARS-CoV-2 agents. Therefore, there is a demand for the development of improved sensors to monitor its activity. Here, we report a pair of ge...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Anupriya M. Geethakumari (17052375) (author)
مؤلفون آخرون: Wesam S. Ahmed (10170053) (author), Saad Rasool (9764093) (author), Asma Fatima (17329974) (author), S. M. Nasir Uddin (18420792) (author), Mustapha Aouida (417652) (author), Kabir H. Biswas (5705864) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
الوصف
الملخص:<p dir="ltr">The main protease, M<sup>pro</sup>, is critical for SARS-CoV-2 replication and an appealing target for designing anti-SARS-CoV-2 agents. Therefore, there is a demand for the development of improved sensors to monitor its activity. Here, we report a pair of genetically encoded, bioluminescence resonance energy transfer (BRET)-based sensors for detecting M<sup>pro</sup> proteolytic activity in live cells as well as in vitro. The sensors were generated by sandwiching peptides containing the M<sup>pro</sup> N-terminal autocleavage sites, either AVLQSGFR (short) or KTSAVLQSGFRKME (long), in between the mNeonGreen and NanoLuc proteins. Co-expression of the sensors with M<sup>pro</sup> in live cells resulted in their cleavage while mutation of the critical C145 residue (C145A) in M<sup>pro</sup> completely abrogated their cleavage. Additionally, the sensors recapitulated the inhibition of M<sup>pro</sup> by the well-characterized pharmacological agent GC376. Further, in vitro assays with the BRET-based Mpro sensors revealed a molecular crowding-mediated increase in the rate of M<sup>pro</sup> activity and a decrease in the inhibitory potential of GC376. The sensors developed here will find direct utility in studies related to drug discovery targeting the SARS-CoV-2 M<sup>pro</sup> and functional genomics application to determine the effect of sequence variation in M<sup>pro</sup>.</p><p><br></p><h2>Other Information</h2><p dir="ltr">Published in: Communications Chemistry<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1038/s42004-022-00731-2" target="_blank">https://dx.doi.org/10.1038/s42004-022-00731-2</a></p>